Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach

Authors

  • Srdjan Gavrilovic Intensive Care Unit, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia https://orcid.org/0000-0002-7752-3833
  • Ana Andrijevic Intensive Care Unit, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
  • Aida Mujakovic Department of Internal Medicine, General Hospital “Prim. Dr. Abdulah Nakaš”, Sarajevo, Bosnia and Herzegovina Sarajevo Medical School, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina https://orcid.org/0000-0002-0022-1482
  • Yewande Odeyemi Department of Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA https://orcid.org/0000-0002-4446-198X
  • Belma Paralija Clinic for Pulmonary Diseases, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina https://orcid.org/0000-0001-7556-671X
  • Ognjen Gajic Department of Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA https://orcid.org/0000-0003-4218-0890

DOI:

https://doi.org/10.17305/bjbms.2019.3977

Keywords:

Pneumonia, corticosteroids, C-reactive protein, biomarkers, intensive care unit, ICU

Abstract

Pneumonia is the leading infectious cause of death worldwide. While inflammation is critically important in host response to microbial invasion, exaggerated inflammation can damage the lungs, contributing to respiratory failure and mortality. Corticosteroids are effective in reducing inflammation and can also cause immune suppression. Presently, clinicians are unable to reliably distinguish between exaggerated and appropriate immune response and thus cannot rapidly identify patients most likely to benefit from adjunctive corticosteroids. In this review, we propose a biomarker-guided, precision medicine approach to corticosteroid treatment, aimed to give these medications at appropriate dose and time and only to patients who have exaggerated inflammation.

Author Biographies

  • Aida Mujakovic, Department of Internal Medicine, General Hospital “Prim. Dr. Abdulah Nakaš”, Sarajevo, Bosnia and Herzegovina Sarajevo Medical School, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina
    Department of Internal Medicine
  • Yewande Odeyemi, Department of Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Department of Pulmonary Medicine
  • Ognjen Gajic, Department of Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Department of Pulmonary Medicine
Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach

Downloads

Additional Files

Published

08-11-2019

Issue

Section

Reviews

Categories

How to Cite

1.
Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach. Biomol Biomed [Internet]. 2019 Nov. 8 [cited 2024 Mar. 19];19(4):315-20. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/3977